Bioinformatician - Neeson Laboratory

Company description:

Peter MacCallum Cancer Centre - Peter Mac is one of a handful of integrated cancer research, education and treatment centres in the world. Each day our team strives to provide the very best in cancer care, even better treatments and potential cancer cures for all people affected by cancer.

Job description:

At Peter Mac we aim to continuously improve cancer care, research and education across all cancers and for all people affected by cancer: changing lives, breaking new ground. Everything we do is underpinned by our core values, Excellence, Compassion and Innovation. Welcoming people from a wide variety of different backgrounds and experiences is critical to fostering innovation, cultivating compassion, attracting and retaining top talent and providing the best possible cancer care for our patients.

YOUR ROLE IN OUR FUTURE

Bioinformatician (Neeson Laboratory)

Fixed Term, Full Time - Two year contract
1RA5 - 1RA10

This is an exciting opportunity for a motivated bioinformatician to join the Neeson Lab (HITRL) in the cancer immunology program at Peter Mac. The lab is focused on developing new immunotherapy strategies to treat cancer patients. To do this we explore the human tumour immune microenvironment (TIME) and use these findings to devise novel combination treatments with immunotherapy.

At the Neeson Lab, we explore novel CAR-T cell strategies to improve outcomes in patients with solid cancers. We will use gene editing approaches and in vitro and in vivo models to address current hurdles to CAR-T cell efficacy in solid tumours (breast, prostate and ovarian cancers). This includes exploring the mechanisms whereby CD4+ T cells are important for CAR-T cell anti-tumour efficacy, and novel engineering approaches to drive improved CAR-T cell function in the TME.

This position will support the bioinformatics analysis of cancer research projects at Peter Mac. This position will work under the Neeson Laboratory and the Bioinformatics Core Facility, to analyse next generation sequencing and other high-throughput genomics data using best-practice methods. This position will work and communicate closely with bioinformaticians and immunologists to deliver analysis results. For more information on recent publications and projects currently running in the Neeson Lab see: https://www.petermac.org/research/labs/paul-neeson. The lab welcomes applications from people of diverse backgrounds.

This is a full-time position for a fixed term of 24 months, with the possibility of extension. Remuneration will be commensurate with qualifications and experience as per the Allied Health Professionals (Victorian Public Sector) (Single Interest Employers) Enterprise Agreement 2021 - 2026 from 1RA5 ($84,718.40 per annum) to 1RA10 ($103,771.20 per annum).

For further information about this opportunity, please review the position description or contact Professor Paul Neeson (Head, HITRL) via email in the first instance.

Applicants to this role should provide a covering letter, resume and response to selection criteria outlining relative key skills and experience to assist us with our assessment.

Applications will be closed on: 11:59pm Thursday 28th March 2024.

Hiring Manager: Prof Paul Neeson
Email: ***********@petermac.org

For further information about this opportunity, click Apply to be redirected to the Peter Mac Careers page where you can review the position profile. Alternatively, please contact us for a confidential discussion.

Peter Mac requires its staff to be fully vaccinated against COVID-19. Please contact us if you would like to discuss this requirement.

WHY WORK FOR PETER MAC
• Peter Mac offer a range of benefits which support our people both personally and professionally.
• Our staff benefits include award winning facilities, professional development and events, a health and wellbeing program, flexible work practices and policies and financial benefits such as salary packaging.
• We encourage applications from Aboriginal and Torres Strait Islander people, all members of the LGBTQI community and people with a disability.